Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Prolotherapy for TMJ Subluxation
NCT03655275Phase 1Unknown
- Start
- Aug 2018
- Primary completion
- Sep 2018
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of platelet-rich plasma in Temporomandibular joint subluxation. Primary endpoint: Subjective pain experience at 40 weeks. Status: unknown.
02
Drugs
platelet-rich plasma
03
Conditions
Temporomandibular joint subluxation
Beyond the preview
Go deeper on NCT03655275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655275.